- News & Analysis
Page 863
Lysogene to grow after Novo Seeds investment
The Novo subsidiary has invested in a $22.5m round for the biotechnology company that also featured Sofinnova Partners and InnoBio.
May 28, 2014BBI to be floated on London Stock Exchange
Owner Alere is using the floatation to pay down debt.
May 28, 2014Legend tells of $500m for new fund
Legend Capital, which makes investments on behalf of conglomerate Legend Holdings, plans to start investing from LC Fund VI this month.
May 27, 2014Cambridge will not forget
A new method of generating mature nerve cells could greatly enhance understanding of neurodegenerative diseases such as Alzheimer's.
May 27, 2014iRhythm on the pulse with $17m
Novo has led a $17m series E investment in iRhythm Technologies with existing backer Norwest Venture Partners.
May 26, 2014Assembly Pharma and Ventrus Biosciences agree to merge
The pharmaeutical companies will form a new entity call Assembly Biosciences, which will aim to produce a treatment for hepatitis B.
May 23, 2014Amgen-backed Ardelyx files for $69m IPO
The metabolic disease-focused pharmaceutical company is set to target $69m when it goes public.
May 23, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin